Variant report
Variant | esv1812328 |
---|---|
Chromosome Location | chr4:130280857-130282466 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548330428 | chr4:130280893-130280894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557103435 | chr4:130280925-130280926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185572188 | chr4:130280929-130280930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534312849 | chr4:130280965-130280966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372442032 | chr4:130280966-130280967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs117775299 | chr4:130281083-130281084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs72927081 | chr4:130281084-130281085 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs146257451 | chr4:130281085-130281086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556417379 | chr4:130281086-130281087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72927083 | chr4:130281110-130281111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190832092 | chr4:130281132-130281133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142695637 | chr4:130281166-130281167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78695647 | chr4:130281200-130281201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144156478 | chr4:130281207-130281208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182071066 | chr4:130281242-130281243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532565285 | chr4:130281243-130281244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148500125 | chr4:130281283-130281284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs28612520 | chr4:130281352-130281353 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs530344410 | chr4:130281449-130281450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548537236 | chr4:130281504-130281505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566877433 | chr4:130281514-130281515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs72688760 | chr4:130281557-130281558 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs551915909 | chr4:130281559-130281560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377261713 | chr4:130281570-130281571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552692744 | chr4:130281580-130281581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184631334 | chr4:130281611-130281612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs28580176 | chr4:130281632-130281633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538021490 | chr4:130281726-130281727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188212598 | chr4:130281736-130281737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181320055 | chr4:130281758-130281759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185532785 | chr4:130281869-130281870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs10020190 | chr4:130281938-130281939 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs571698270 | chr4:130281959-130281960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545440254 | chr4:130281992-130281993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs142797259 | chr4:130282041-130282042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550791172 | chr4:130282058-130282059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555080348 | chr4:130282115-130282116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575450922 | chr4:130282210-130282211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372678080 | chr4:130282276-130282277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150630183 | chr4:130282277-130282278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544758897 | chr4:130282358-130282359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562964445 | chr4:130282398-130282399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs118079743 | chr4:130282410-130282411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35536616 | chr4:130282413-130282414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:130277200-130284000 | Weak transcription | Colon Smooth Muscle | Colon |
2 | chr4:130277600-130284200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr4:130279000-130281600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr4:130279200-130281600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr4:130279800-130281200 | Enhancers | Fetal Lung | lung |
6 | chr4:130280400-130283600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr4:130280400-130283600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr4:130280400-130283800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
9 | chr4:130280400-130283800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
10 | chr4:130280400-130283800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
11 | chr4:130280400-130283800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr4:130280400-130283800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr4:130280400-130283800 | Weak transcription | HUVEC | blood vessel |
14 | chr4:130280400-130284000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr4:130280400-130284400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr4:130280400-130284600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
17 | chr4:130280400-130284600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr4:130281600-130284400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |